The role of progesterone (P 4 ) in the regulation of inflammatory mediators interleukin-8 (IL-8), monocyte chemoattractant protein-1, and cyclooxygenase-2 (COX-2) and in the recruitment of leukocyte subpopulations in the endometrium has been examined, by employing a model of P 4 withdrawal and maintenance in vivo. Messenger RNA and protein expression have been investigated in endometrial biopsies: 1) during the midsecretory phase (LHϩ8 to 10); during the maintained luteal phase (P 4 administered vaginally for 4 days from LHϩ8) and biopsies collected 2) 24 h and 3) 48 h post withdrawal of P 4 ; and 4) during pseudo pregnancy (lifespan of corpus luteum extended by 7 days with CG; (decidua collected from women with 5) an ectopic gestation and 6) from women undergoing first-trimester termination of pregnancy). CD56ϩ large granular lymphocytes remain the major leukocyte subtype, both 24 and 48 h after P 4 withdrawal, and in decidua (CG supported or ectopic). Higher numbers (P Ͻ 0.05) of macrophages (CD68ϩ) were present in endometrium 48 h post P 4 withdrawal and in pseudo pregnant endometrium, compared with normal decidua. Significantly more macrophages (P Ͻ 0.01) were present in decidua from an ectopic pregnancy. A significant elevation of IL-8 (P Ͻ 0.01) and COX-2 (P Ͻ 0.05) messenger RNA was detected 48 h post P 4 withdrawal. Evidence is provided for up-regulation of IL-8 and COX-2 in response to P 4 withdrawal. (J Clin Endocrinol Metab 84: 240 -248, 1999) 
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withdrawal. (J Clin Endocrinol
Metab 84: 240 -248, 1999) P ROGESTERONE (P 4 ) is essential for nurturing a successful pregnancy. The local tissue response to withdrawal of P 4 , resulting in menstruation, shows many features characteristic of an inflammatory response, i.e. release of prostaglandins (PGs), increased permeability of blood vessels, and an abundance of leukocytes in the endometrium (1) . However, the precise local mechanisms regulating normal endometrial function; i.e. implantation, decidualization, and menstruation; are unknown. The numbers and types of leukocytes in human endometrium and decidua varies during the menstrual cycle, with implantation, and throughout pregnancy (2) . It is thus likely that there is both an endocrine and paracrine control of leukocyte migration to, and replication within, these tissues (3). Macrophages and lymphocytes constitute the major leukocyte subpopulation in nonpregnant endometrial stroma (4) . Only small numbers of polymorphonuclear (PMN) leucocytes are present throughout the normal endometrial cycle, except immediately premenstrually and during menstruation (5) . It is not known, however, whether in situ proliferation (6) or migration from the peripheral circulation (7) is the event responsible for the late-luteal-phase increase in leukocyte subpopulations. The phenotypically unique population of large granular lymphocytes (LGLs; CD56ϩ, CD16-, CD3-) increases in the late luteal phase (8) . There are lines of evidence to suggest that P 4 is essential for the appearance and survival of CD56ϩ cells, because their presence is observed in ovariectomized women only after treatment with both estrogen (E 2 ) and P 4 (9) . Furthermore, there is in vitro evidence demonstrating P 4 dependence (10) . An indirect regulation is supported by the absence of steroid receptor expression by these cells (9) . In the absence of pregnancy, these unique cells undergo apoptosis before the influx of neutrophils, a feature of menstruation (4) .
Monocyte chemoattractant protein-1 (MCP-1), a 76-aminoacid basic protein, is a specific chemoattractant and activator of monocytes (also T cells, NK cells, eosinophils, and basophils). MCP-1 is secreted by a number of cell types: endothelial cells (11) , fibroblasts (12) , monocytes (13) , and lymphocytes (14) . Interleukin 8 (IL-8) recruits and activates neutrophils (15) and T lymphocytes (16) . IL-8 is produced by a variety of cell types: monocytes, fibroblasts, epithelial and endothelial cells, lymphocytes, and CD56ϩ large granular lymphocytes (17, 18) . The chemokine, IL-8, has been detected in human endometrium (19, 20) . Specifically, IL-8 has been immunolocalized to the perivascular cells of blood vessels in endometrium and early decidua (20, 21) . Cyclooxygenase-2 (COX-2), the inducible isoform of the enzyme synthesizing PGs, is a further inflammatory mediator that has been localized to perivascular cells and glandular epithelium in endometrium. A significant increase in COX-2 expression has been reported premenstrually and menstrually (21) .
The present study has examined the role of P 4 (using a model of P 4 withdrawal and maintenance in vivo) in the expression of the inflammatory mediators MCP-1, IL-8, and COX-2, and the recruitment of selected leukocyte subpopu-lations in endometrium before the onset of menstrual bleeding and in early pregnancy decidua.
Subjects and Methods
Ethical approval for the study was obtained from Lothian Research Ethics Committee (reference no. 1702/94/6/1). Informed written consent was obtained from all subjects.
Twenty fertile women, using barrier contraception, or subjects who had been sterilized were recruited. All women reported regular menstrual cycles (25-35 days) . The timing of the onset of the LH surge was determined by subjects themselves using a commercially available home urine LH kit (Conceive; Quidel, San Diego, CA). Women tested urine samples twice daily (0800 and 1800 h) from cycle day 10 (10 days after the start of menses). Detection of the urine LH surge (taken as the day on which doubling of the basal LH levels occurred) thereafter was confirmed by RIA. The women participated in one of four groups as detailed: 1) an endometrial biopsy (Pipelle, Laboratoire CCD, Paris, France) was collected in (group A) the normal midluteal phase (LH peak ϩ 8 to 10), n ϭ 5; 2) menstrual [to time the onset of simulated menstruation accurately, P 4 (200 mg Cyclogest, Hoechst UK Ltd, Hounslow, UK; vaginally twice daily) was administered from day LH peak ϩ 8 in the luteal phase for 4 days. An endometrial biopsy (pipelle suction curette) was collected (group B) 24 h (n ϭ 5) and (group C) 48 h (n ϭ 5) after ceasing P 4 administration; (3) extended luteal phase (pseudo pregnancy): (group D) the luteal phase was extended for 7 days by extending the lifespan of the corpus luteum by injections of CG from day LH peak ϩ 8 for 14 days to simulate very early pregnancy (n ϭ 5). Incremental doses of CG, ranging from 125-20,000 IU, were administered (22) . In addition, early pregnancy decidua was collected from: (E) women with a gestation ectopic to the uterus (fallopian tube, n ϭ 5). Women with an ectopic gestation who described vaginal bleeding were excluded. Women were diagnosed at an early stage by ultrasound and serum CG concentration. (F) Early pregnancy decidua was collected from women undergoing surgical termination of pregnancy (35-63 days), n ϭ 8. Decidua was collected, away from the implantation area, by careful curettage of the uterine wall before vacuum aspiration of the products of conception with a suction catheter. Decidua parietalis (without trophoblast) was subsequently confirmed by examination of hematoxylin and eosin-stained sections of each biopsy. Tissue sections were also stained with cytokeratin (Dako Corp. Laboratories, High Wycombe, UK; code: M0821) to confirm presence or otherwise of trophoblast cells within the decidual tissue.
Immunohistochemistry
Leukocyte subpopulations. All endometrial biopsies were fixed in 10% neutral buffered formalin at 4 C overnight, rinsed, and stored in 70% ethanol and thereafter routinely wax embedded. Sections (5 m) were cut for immunolocalization using commercially available monoclonal antibodies: 1) CD56ϩ lymphocytes (Zymed, San Francisco, CA); 2) neutrophils (neutrophil elastase, Dako Corp. Laboratories, code N752); 3) macrophages (CD68, Dako Corp. Laboratories, code M0876); and 4) hematoxylin and eosin staining (H&E) for routine histology.
Tissue sections were dewaxed and rehydrated in descending grades of alcohol. Nonspecific endogenous peroxidase activity was blocked by treatment with 3% hydrogen peroxide in distilled water for 5 min. No antigen retrieval step was necessary for demonstration of neutrophil elastase. Antigen retrieval was necessary for localization of CD56 ϩ lymphocytes and macrophages (as follows).
CD56ϩ lymphocyte immunostaining. Tissue sections were microwaved at high power in 0.01 mol/L sodium citrate buffer (pH 6.0) for 20 min and then allowed to stand for a further 20 min. Sections were subsequently washed in buffer before a nonimmune block.
Macrophage immunostaining. Tissue sections were subjected to an enzyme digestion with 0.1% trypsin in 0.1% calcium chloride at pH 7.8. The digestion was conducted at 37 C for 15 min; and subsequently, enzyme activity was destroyed by washing in tap water.
All tissue sections were exposed to a nonimmune block with normal horse serum performed for 20 min at room temperature. Tissue sections were then incubated with the appropriate primary antibody for 60 min at 37 C: 1) CD56 dilution, 1 in 250; 2) neutrophil elastase dilution, 1 in 50; and 3) macrophages (CD68) dilution, 1 in 50.
Negative controls were included by replacing the primary antibody with mouse Ig at the same concentration as the primary antibody. Sections were labeled with an avidin-biotin peroxidase detection system (Vector Stain, Vector Laboratories, Inc., Peterborough, UK). Tissue sections were incubated for 2-10 min with diaminobenzidine (DAB) solution (DAB Kit, Vector Laboratories, Inc.) for color development. Thereafter, sections were counterstained with hematoxylin, dehydrated and cleared in xylene, and mounted in Pertex.
Image analysis
Quantification of leukocyte subpopulation immunoreactivity in endometrial stroma employed computerized image analysis (23) . The system used has been previously described in detail (23, 24) . To represent the amount of positive immunoreactivity, in terms of number of cells, the average dimensions of each leukocyte and stromal cell were estimated. Ratios were then converted by a conversion factor, such that the data could be expressed as percentage of cells in the stroma.
In vitro studies
Samples of endometrium were transported to the laboratory in icecold RPMI 1640 and were cultured for 24 h in RPMI supplemented with 10% FCS (Gibco, Paisley, UK) and antibiotics (penicillin, streptomycin, and gentamycin). After 24 h culture in 5% CO 2 in air, media were removed, divided into aliquots, and stored at Ϫ20 C until assayed. Tissue weight was determined after the incubation period. IL-8 and MCP-1 were assayed by enzyme-linked immunosorbent assay (ELISA), following the method of Ida et al. (25) for IL-8 and Ida et al. (26) for MCP-1. Antisera and standards were the gift of Toray Industries Inc. (Tokyo, Japan). PG F 2␣ (PG 2␣ ) and its metabolite 13, 14 dihydro-15-keto PGF (PGFM) were assayed by ELISA using specific antibodies and peroxidase-conjugated PGs as the label.
All concentrations of cytokines were corrected for endometrial weight.
Semiquantitative RT-PCR
The messenger RNA (mRNA) expression levels of the inflammatory mediators IL-8, MCP-1, and COX-2 were monitored by RT-PCR. Total RNA was extracted from endometrium from all study groups (n ϭ 16) using the Ultraspec RNA Isolation system (Biotecx, Biogenesis, Poole, UK). To obtain quantitative information about mediator mRNA levels, RT-PCR was first conducted for the housekeeping gene glyceraldehyde phosphate dehydrogenase (GAP-DH). RNA samples were reverse transcribed using Avian Myeloblastosis Virus Reverse Transcriptase (Promega Corp. Ltd, Southampton, UK) and an antisense oligonucleotide primer specific for GAP-DH, 5Ј labeled with biotin (Oswell, Southampton, UK) (see Table 1 ). The gene specific complementary DNA (cDNA) generated was then subjected to PCR using AmpliTaq DNA Polymerase (Perkin-Elmer Corp., Beaconsfield, UK) with sense and the same antisense oligonucleotides (described in Table 1 ) for 26 cycles of 94 C for 1 min, 60 C for 1 min, and 72 C for 2 min, followed by a final extension of 10 min at 72 C. This produced a 1103-bp amplicon (see Fig. 3 ).
To enable quantification of RNA loading, samples were amplified alongside a range of standards of known concentrations (from 15.7-250 ng total RNA). The product yield was determined by ELISA using a high-capacity streptavidin-coated microtitre plate (Boehringer Mannheim, Sussex, UK). After alkaline denaturation, the bound DNA was hybridized at 50 C for 1 h with a digoxigenin-labeled 29-bp oligonucleotide (Table 1) , complementary to the internal cDNA sequence of the GAP-DH-amplified region diluted to 10 nmol/L in Easy Hyb hybridization buffer (Boehringer Mannheim). After removal of nonspecifically bound probe, by repeated washing, the probe-amplicon complex was detected by addition of a sheep antidigoxigenin antibody conjugated with peroxidase enzyme (Boehringer Mannheim). Substrate development produced a color change, and the absorbance was measured at 450 nm by a plate reader. A standard curve was plotted of RNA standards.
Samples were then subjected to RT-PCR for IL-8, MCP-1, and COX-2, using optimized programs. Oligonucleotide primers were designed for each mediator (Oswell) (see Table 1 ). Gene specific RT of 60 ng of template RNA was conducted, as for GAP-DH, and the total volumes of products were amplified using the following PCR programs: 1 min at 94 C, 1 min at X C, and 1 min at 72 C, for a selected number of cycles (see Table 1 ), followed by a final extension for 10 min at 72 C; where X is the specific annealing temperature for each primer pair (63 C for IL-8, 60 C for MCP-1 and COX-2). An ELISA was conducted to quantitate RT-PCR product yield. Menstrual phase endometrial sample was included as a quality control (QC), and mediator amplicon concentrations were expressed as a ratio of sample signal to QC signal. Omission of template served as a negative control for all RT-PCRs. The reproducibility of RT and PCR stages was assessed, as well as determining the intra-and interassay variations of the ELISA. All were determined to be below 7%, based on the variability between a minimum of 6 samples.
Serum RIAs for P 4 and estradiol (E 2 ) concentrations
A venous blood sample was collected at the time of biopsy. Serum was separated and frozen at Ϫ20 C for subsequent RIA of E 2 and P 4 (27) . The interassay coefficients of variation for these assays were 11.0 and 10.0%, respectively: interassay coefficients of variation were 8.0 and 8.0%, respectively.
Bleeding profiles
All subjects were requested to keep a diary of menstrual bleeding experience after the attendance for endometrial biopsy and to continue the bleeding record until the cessation of menstruation.
Immunolocalization of inflammatory mediators (IL-8, MCP-1, and COX-2)
Detailed methodology for immunolocalization of the inflammatory mediators IL-8, MCP-1, and COX-2 has already been reported (20, 21) .
Briefly, immunolocalization of the chemokines IL-8 and MCP-1 required frozen sections to be lightly fixed in 10% neutral buffered formalin for 10 min at room temperature. Endogenous peroxidase activity was blocked by immersion of slides in 3% hydrogen peroxide in distilled water for 5 min at room temperature. Dilute nonimmune goat serum (Vectastain Elite PK-6101, Vector Laboratories, Inc.) was applied for 20 min in a humidified chamber. Excess serum was removed and either IL-8 rabbit polyclonal antibody (1:500 dilution) was applied for 60 min at 37 C, or MCP-1 rabbit polyclonal antibody (1:400 dilution) was applied for 17 Ϯ 1 h (overnight) at 4 C (both antibodies raised in-house). Sections were thereafter labeled with an avidin biotin peroxidase detection system (Vectastain, Vector Laboratories, Inc.), as previously described. Positive antibody binding was identified by application of DAB solution (DAB Kit, Vector Laboratories, Inc.). Sections were counterstained with hematoxylin.
Immunolocalization of COX-2 was conducted on paraffin sections. A microwave antigen-retrieval step (10 min, sodium citrate buffer, pH 6.0) was required to expose the epitope. Incubation with primary antibody (PG27, rabbit polyclonal, Oxford Biomedical, Biogenesis) at a dilution of 1 in 250 was conducted for 60 min at 37 C. Positive controls were frozen tonsil tissue sections for IL-8 and MCP-1, and third-trimester fetal membranes for COX-2 immunolocalization. Negative controls were included and were either nonimmune rabbit Ig or primary antibody preabsorbed with appropriate synthetic peptide (IL-8 or MCP-1) at 100 g/mL, substituting for the primary antibody.
Analysis of data
Evaluation of leukocyte immunostaining, as measured by image analysis, ELISA measurements, RIA of E 2 and P 4 concentrations, and RT-PCR ELISA, were all subjected to an ANOVA, with a Fisher's protected least significant difference (PLSD) to assign significance, to evaluate whether significant differences were present.
Results

Histological features
All biopsies conducted in the normal luteal phase (LH ϩ 8 to 10) were consistent with the secretory phase histological features appropriate with LH dating. Endometrium, examined 24 h after P 4 withdrawal (simulated menstruation), displayed overall secretory appearances and evidence of some LGL infiltration. PMN leukocytes were not evident. There was spiral artery development in three of the five women biopsied.
Endometrial biopsies, collected from women 48 h after P 4 withdrawal, showed spiral vessel development in the majority of subjects and, in two of these women, an infiltrate of LGLs. No PMN leukocyte infiltration was noted with routine histology. Features of tissue breakdown were, however, evident at 48 h after P 4 withdrawal, in contrast with the histological appearances of tissue collected in the secretory phase or in early-pregnancy decidua.
Histological appearances of endometrium, where the gestation was ectopic and where endometrium was maintained with CG, showed very similar histological features. Biopsies were described as either late secretory or hypersecretory in appearance. All biopsies showed spiral vessel development and infiltration with LGLs. Stromal decidualization was observed particularly in those biopsies where the gestation was ectopic.
Bleeding profiles
All women biopsied during the normal luteal phase at LHϩ 8 -10 commenced bleeding attributable to natural lu- teolysis, within 1-7 days after biopsy. In this context, the cycle length for the five subjects varied between 23 and 30 days. Subjects biopsied after withdrawal of P 4 (simulated menstruation) commenced bleeding 24 h or longer after biopsy when the endometrium was sampled 24 h after cessation of P 4 . Women biopsied 48 h after cessation of P 4 all bled (4 -6 days) from the day on which the biopsy was conducted. The group of women in whom the luteal phase was maintained for 7 days with exogenous CG all commenced a withdrawal bleed either 24 h (one subject) or 48 h (four subjects) after cessation of CG. The withdrawal bleeding lasted between 2 and 11 days. Figure 1 displays the distribution of leukocyte subpopulations (macrophages, CD68; CD56ϩ lymphocytes; neutrophils) in endometrium: between days LH ϩ 8 to 10 of the normal cycle, n ϭ 5 (A); 24 h after withdrawal of P 4 , n ϭ 5 (B); 48 h after withdrawal of P 4 , n ϭ 5 (C); in endometrium maintained with CG for 14 days, n ϭ 5 (D); in decidua from women with an ectopic pregnancy, n ϭ 5 (E); and in normal decidua, n ϭ 8 (F). CD56ϩ cells were the major leukocyte subtype in the luteal phase (LH ϩ 8 to 10) and remain the major leukocyte subtype both 24 and 48 h after P 4 withdrawal and in decidua (either exogenously supported by CG, ectopic or normal). No significant changes in CD56ϩ large granular lymphocytes (LGLs) were detected in the model situation in this study. In endometrium collected from patients where the gestation was ectopic to the uterus, an increase (P Ͻ 0.001) in macrophages was observed, compared with normal decidua (intrauterine pregnancy). Higher numbers (P Ͻ 0.05) of macrophages (CD68ϩ) were present in endometrium 48 h after P 4 withdrawal (group C) and in pseudopregnant endometrium (group D), compared with normal decidua.
Leukocyte subpopulations
Inflammatory mediator mRNA (RT-PCR)
A band of 1103 bp, corresponding to the region of the GAP-DH cDNA amplified, was detected for all samples and standards. The signal intensity for the standards increased with an increasing amount of template, producing a linear standard curve of RNA loading (x) plotted against absorbance of products (y); y ϭ 0.006x ϩ 0.138 (Fig. 2) . Equal amounts of RNA (60 ng) were subsequently amplified for IL-8, MCP-1, and COX-2. The QC (menstrual endometrium) exhibited a strong signal of the correct molecular weight for IL-8 (298 bp), MCP-1 (210 bp), and COX-2 (350 bp). Distinct variations in sample signal intensity were observed (Fig. 3) . A significant elevation in IL-8 mRNA (P Ͻ 0.01) was detected 48 h after P 4 withdrawal, above control (LH ϩ 8 to 10), and pharmacologically induced pseudopregnancy (Fig. 4a) . There was also a significant increase (P Ͻ 0.05) in COX-2 mRNA expression at 48 h after P 4 withdrawal (Fig. 4c ) above control endometrium (LH ϩ 8 -10). A similar trend in MCP-1 mRNA expression was observed after P 4 withdrawal, but significance was not reached (Fig. 4b) . P 4 maintenance (groups D and E) resulted in generally reduced expression of IL-8 and COX-2 (slightly higher levels of IL-8 mRNA were detected in decidua collected from ectopic pregnancy). In contrast, MCP-1 mRNA transcript numbers remained high in both pregnant groups.
Inflammatory mediator protein (ELISA)
A significant increase in IL-8 protein, as measured by ELISA, was detectable in cultured tissue at 48 h (P Ͻ 0.01) after in vivo P 4 withdrawal (group C), when compared with control (LH ϩ 8 to 10) endometrium (group A), exogenously maintained endometrium (group D), and normal decidua (group F; Fig. 5 ). The increased MCP-1 levels in culture medium 48 h after P 4 withdrawal (group C) were elevated but not significantly different from control (group A; see Fig. 5 ).
PGF 2␣ release from cultured endometrium rose significantly from 46 Ϯ 12 pg/mL to 170 Ϯ 52 pg/mL (P Ͻ 0.05) and 451 Ϯ 35 pg/mL (P Ͻ 0.001) after withdrawal of P 4 for 24 (group B) and 48 h (group C), respectively (Fig. 6) . The changes in PGFM parallel the changes in PGF 2␣ but were comparatively small and were not able to account for the changes seen in PGF 2␣ .
Results were expressed as cytokine production per milliliter of medium, because tissues from groups B and C (24 and 48 h after P 4 withdrawal) tended to disintegrate in vitro. Mean 
Inflammatory mediator protein immunohistochemistry
Positive immunostaining for IL-8 protein was evident in a perivascular location in endometrial biopsies from control endometrium (LHϩ8 -10) and decidua. Intense immunoreactivity was detected in the perivascular area, both 24 h (Fig.  7a ) and 48 h post P 4 withdrawal. Immunostaining was additionally present in glandular epithelium and stroma 48 h after P 4 withdrawal, corresponding to tissue breakdown. Strong immunoreactivity was also evident in decidua where the gestation was ectopic or endometrium maintained with exogenous CG (Fig. 7b) . Negative control displayed absent immunoreactivity (Fig. 7d) COX-2 positive immunoreactivity in glandular epithelium was particularly noted to display heterogeneous expression, both 24 and 48 h post P 4 withdrawal (Fig. 7c) . COX-2 immunoreactivity was lowest in normal decidua and endome- FIG. 4. a, IL-8 . Low levels of expression of IL-8 were detected in the endometrium from the control group (group A). The signal increased slightly 24 h after P 4 withdrawal (group B); and 48 h after withdrawal (group C), a significant elevation in mRNA transcript expression was detected (P Ͻ 0.01), compared with the control group. In the pseudo pregnant women (D), levels of IL-8 transcripts were low (P Ͻ 0.01 vs. group C), and slightly higher levels were apparent in the endometrium collected from ectopic pregnancy (E). RNA extracted from endometrium derived from 15 subjects; thus n ϭ 3 in each group (A-E). b, MCP-1. Variations were apparent in the levels of MCP-1 mRNA in the study groups (not significant). The lowest number of mRNA transcripts were detected in the control group (A), with a trend towards an increase after P 4 withdrawal (B and C). In the pseudopregnant (D) and ectopic endometrium (E), expression of MCP-1 was comparable and generally elevated, compared with midsecretory levels (A). c, COX-2. A pattern of COX-2 expression levels was detected, similar to that of IL-8 in the study patients. Very low levels of COX-2 mRNA were present in the control group (A), and a significant increase (P Ͻ 0.05) was observed 48 h (C), but not 24 h (B), after P 4 had been withdrawn. COX-2 expression in the pseudopregnant (D) and ectopic pregnancies (E) were consistent with those during the midsecretory phase (A).
trium exogenously maintained with CG. No immunoreactivity was observed in negative control (Fig. 7e) . Table 2 represents the serum P 4 (nmol/L) and E 2 (pmol/L) concentrations at the time of endometrial biopsy. Significantly lower serum P 4 concentrations were present, both 24 h (P ϭ 0.0056) and 48 h (P ϭ 0.0012) after P 4 withdrawal, compared with the luteal-phase control group. Serum E 2 concentrations were significantly higher in subjects with an ectopic pregnancy (P Ͻ 0.01, Group E) and CG-maintained endometrium (P Ͻ 0.02, Group D), compared with women in the control group (group A) and 24 h (group C, P Ͻ 0.01) and 48 h (group D, P Ͻ 0.01) post P 4 withdrawal.
Serum P 4 and E 2 concentrations
Discussion
Endocrine-immune interactions in the endometrium are involved in mechanisms regulating normal endometrial function. Furthermore, the role of PGs in these mechanisms has long been recognized (28) . We have previously hypothesized (23) that the withdrawal of P 4 [via up-regulation of sex steroid receptors after antigestogen administration (29) ] results in an increase in chemokines, IL-8 and MCP-1 (23, 30) . A leukocyte influx is thus orchestrated and further augmented by increased PG synthesis via COX-2. As a consequence of reduced PG dehydrogenase (PGDH) activity (31) , there are increased concentrations of active PG E (PGE) which has the ability to synergize with IL-8 (32) to facilitate a leukocyte influx. Such a cascade of events is crucial to understanding the mechanisms of onset of menstruation and, indeed, early pregnancy failure.
The major leukocyte subpopulations detected were the CD56ϩ large granular lymphocytes (LGLs) and macrophages (2). The observations are consistent with reports of leukocyte subpopulations in the literature (4, 33, 34) . In this study, the withdrawal of P 4 in vivo, in a regimen designed to mimic the physiological fall in P 4 levels, was not associated with any detectable changes in CD56ϩ LGL subpopulations. There were, however, higher numbers of macrophages in ectopic decidua, pseudopregnant endometrium, and endometrium 48 h post P 4 withdrawal, when compared with normal decidua. Uterine macrophages regulate, in part, local tissue effects of E 2 and P 4 . Changes in macrophage number in the murine uterus correlate with changes in macrophage colony-stimulating factor 1 (CSF-1) levels and a surge of E 2 . In the mouse, E 2 and P 4 have additive effects on macrophage recruitment and activation. Factors other than CSF-1 are involved, and MCP-1 is expressed at higher levels than CSF-1 during early murine pregnancy and is, hence, implicated in macrophage recruitment (35) .
In our in vivo model, serum P 4 concentrations were significantly lowered at 24 h (mean P 4 concentration, 11.3 nmol/L) and at 48 h (mean P 4 , 3.5 nmol/L) after withdrawal of P 4 . This observation concerning leukocyte populations is consistent with our earlier study that reported a significant increase in macrophage numbers at 12 h post antigestogen (mifepristone) administration (23) . Attention is drawn, however, to a potentially different mechanism, i.e. the physiological withdrawal of P 4 that occurs before the onset of menstruation and pharmacological blockade of the P 4 receptor with the antagonist mifepristone. Blockage of the receptor is probably a more rapid event than the physiological withdrawal of P 4 .
The present study clearly supports a role for P 4 in the modulation of key inflammatory mediators, these being IL-8, MCP-1, and COX-2. This is confirmatory evidence for the sex steroid regulation of these mediators in the human endometrium reported by Jones et al. (21) . This is also in agreement with previous reports in the literature. Down-regulation of IL-8 by P 4 has been demonstrated in vitro in endometrial, choriodecidual, and cervical cells (30, 36) . Similar data have been obtained concerning MCP-1 expression, with a negative regulation by P 4 in choriodecidual and breast cancer cells (37) , reinforcing previously demonstrated inhibition by glucocorticoids (38) . Before the discovery of the COX-2 isoform, studies of uterine PG production revealed that release of P 4 premenstrually allowed the full potential of the secretory endometrium to synthesize PGs to be realized (39) . Further, when P 4 levels are maximal, during pregnancy, basal PG production is reduced (40) . This can be mimicked in vitro, with decreased PG release from endometrium in the presence of P 4 (41, 42) . A possible mechanism was reported by Ishihara et al. (1995) (43) who reported a reduction in COX-2 expression in response to P 4 .
This study has, for the first time, described a significant . Groups A-C, D, and F are as previously described (group A, n ϭ 5; group B, n ϭ 5; group C, n ϭ 4; group D, n ϭ 6; group F, n ϭ 5).
elevation in IL-8 and COX-2 mRNA expression levels in an in vivo situation designed to mimic the period immediately before onset of menstruation. Specifically, an elevation in IL-8 and COX-2 mRNA was observed 48 h post P 4 withdrawal. Furthermore, low numbers of IL-8 and COX-2 mRNA transcripts were observed in endometrium, either with a trophoblast ectopic to the uterus or where the corpus luteum had been maintained with exogenous CG. In this particular context, IL-8 mRNA was marginally higher in endometrium where the pregnancy was ectopic to the uterus and in endometrium exposed to exogenous CG administration. This observation coincides with the slight increase in neutrophil numbers observed in endometrium where the pregnancy was ectopic to the uterus. These data support the down-regulation of IL-8 and COX-2 expression by P 4 . Failure to detect a significant rise in MCP-1 mRNA may reflect inherent differences in the role for P 4 in the regulation of this chemokine. It is noted that MCP-1 mRNA transcripts were expressed at a greater level in endometrium exposed to exogenous or endogenous CG. P 4 might thus have a less inhibitory action on MCP-1 expression, when compared with expression of IL-8. Interestingly, and consistent with this statement, decidua (although with a trophoblast ectopic to the uterus) exhibited relatively high levels of MCP-1 immunoreactivity. Differences in the regulation of chemokines IL-8 and MCP-1 have already been reported, including stimulation of MCP-1 by platelet-derived growth factor, interferon ␥, PRL, and LIF (14, 44 -46) . Furthermore, in this context, the high level of MCP-1 expression in the early pregnant uterus correlates with the continued increase in numbers of LGLs and macrophages recruited into decidual stroma (33) . The up-regulation of COX-2 mRNA expression occurs at a time point similar to that of increased expression of IL-8. These two local mediators, i.e. IL-8 and PGE2 (product of COX-2), have been reported previously (32, 47, 48) to act in synergy to facilitate leukocyte recruitment.
Immunolocalization of IL-8 protein was evident in a perivascular location in endometrial tissue, both before and after withdrawal of P 4 and in early pregnancy decidua. Measurements of IL-8 protein from the supernatant of cultured biopsies (by ELISA) in the timed endometrial biopsies were consistent in also demonstrating a significant increase in IL-8 protein 48 h post P 4 withdrawal. The increase in IL-8 protein production coincided with a significant fall in circulating P 4 concentrations. There was a nonsignificant increase in MCP-1 protein (as measured by ELISA in culture supernatants) also at 48 h after withdrawal of P 4 administration. This observation was consistent with the trend for increased MCP-1 mRNA expression. The release of PGE and PGF 2␣ by endometrium plays a critical role in the mechanisms regulating menstruation (28) . Secretory endometrium has a greater capacity for PG synthesis (40, 49) and for PG metabolism (50) . Both of these features are probably dependent on P 4 , because persistent proliferative endometrium has the ability to synthesize PGs but needs arachidonic acid substrate (51) . The effects of P 4 withdrawal are not known. This study shows that P 4 withdrawal leads directly or indirectly to an increase in COX-2 message and PGF 2␣ synthesis. Under the in vitro conditions used here, there was no clear effect on metabolism of the PGs. Moreover, P 4 stimulates PGDH, the enzyme responsible for metabolizing PGF 2␣ and PGE to their inactive 15-keto metabolites. P 4 withdrawal reduces PGDH production perivascularly, hence increasing local concentrations of PGE (31) . This mechanism may be permissive for leukocyte entry into tissues. Thus, P 4 withdrawal may provide an indirect signal necessary for a leukocyte influx.
Thus, there are increasing lines of evidence to support the immune endocrine interactions in the regulation of normal endometrial functions. The features of menstruation and early pregnancy share much in common with an inflammatory reaction, specifically, traffic movement of leukocytes and production of local inflammatory mediators. Data provided herein strongly support a role for IL-8, COX-2, and indeed MCP-1, in the modulation of menstruation and remodeling in endometrial tissues.
